NCT02816021 2026-02-17Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic MelanomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting24 enrolled